跳转至内容
Merck
CN

主要文件

查看所有文档

S6647

[D-Pro4, D-Trp7,9, Nle11]-Substance P Fragment 4-11

≥95% (HPLC)

别名:

D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Nle-NH2

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C58H77N13O10
化学文摘社编号:
89430-34-2
分子量:
1116.31
UNSPSC Code:
12352200
PubChem Substance ID:
24899718
MDL number:
MFCD00133834
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥95% (HPLC)

UniProt accession no.

P20366

storage temp.

−20°C

SMILES string

CCCCC(NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc3ccccc3)NC(=O)C(Cc4c[nH]c5ccccc45)NC(=O)C(CCC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C6CCCN6)C(N)=O

InChI

1S/C58H77N13O10/c1-4-5-18-41(51(61)74)65-55(78)45(27-33(2)3)68-57(80)48(30-36-32-64-40-20-12-10-17-38(36)40)71-56(79)46(28-34-14-7-6-8-15-34)69-58(81)47(29-35-31-63-39-19-11-9-16-37(35)39)70-54(77)44(23-25-50(60)73)67-53(76)43(22-24-49(59)72)66-52(75)42-21-13-26-62-42/h6-12,14-17,19-20,31-33,41-48,62-64H,4-5,13,18,21-30H2,1-3H3,(H2,59,72)(H2,60,73)(H2,61,74)(H,65,78)(H,66,75)(H,67,76)(H,68,80)(H,69,81)(H,70,77)(H,71,79)

InChI key

OFDJVNRFKDPBKR-UHFFFAOYSA-N

Gene Information

human ... TAC1(6863)

Biochem/physiol Actions

A potent substance P antagonist

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
022H06033
022H06032

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

G Bredy-Dobreva et al.
Acta physiologica et pharmacologica Bulgarica, 15(3), 10-15 (1989-01-01)
The effects of a new analogue of substance P (SP-A) and its interaction with substance P (SP) were studied in vitro isolated preparations from rabbit renal arteries and rat renal and pulmonary arteries. SP-A in did not affect the resting
Synthesis of substance P antagonists: [D-Pro4, D-Trp7,9,Nle11]-substance P(4-11).
G Köller et al.
Die Pharmazie, 39(1), 65-67 (1984-01-01)
Ruofan Wang et al.
Cell, 184(1), 106-119 (2020-12-18)
The Coronaviridae are a family of viruses that cause disease in humans ranging from mild respiratory infection to potentially lethal acute respiratory distress syndrome. Finding host factors common to multiple coronaviruses could facilitate the development of therapies to combat current